Abstract
Compared with normal erbB-2 gp185, mutant erbB-2 proteins generated by mutations either in the transmembrane domain or by NH2-terminal deletion are able to transform NIH 3T3 cells at a 10- to 100-fold greater efficiency. Mutant proteins of both classes show increased tyrosine kinase activity, suggesting that an abnormal level of receptor-associated tyrosine kinase activity is a major determinant of erbB-2 oncogenic potential.
Dates
Type | When |
---|---|
Created | 9 years, 10 months ago (Sept. 30, 2015, 3:49 p.m.) |
Deposited | 2 years, 8 months ago (Dec. 15, 2022, 8:56 a.m.) |
Indexed | 2 months, 1 week ago (June 21, 2025, 12:29 a.m.) |
Issued | 36 years, 8 months ago (Dec. 1, 1988) |
Published | 36 years, 8 months ago (Dec. 1, 1988) |
Published Online | 36 years, 8 months ago (Dec. 1, 1988) |
Published Print | 36 years, 8 months ago (Dec. 1, 1988) |
@article{Segatto_1988, title={Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene.}, volume={8}, ISSN={1098-5549}, url={http://dx.doi.org/10.1128/mcb.8.12.5570}, DOI={10.1128/mcb.8.12.5570}, number={12}, journal={Molecular and Cellular Biology}, publisher={Informa UK Limited}, author={Segatto, O and King, C R and Pierce, J H and Di Fiore, P P and Aaronson, S A}, year={1988}, month=dec, pages={5570–5574} }